Search

everythinglearnresearchcommunity

for

Search:↓

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Topical finasteride is a safe and effective treatment for pattern hair loss with fewer side effects than oral finasteride.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

PLD is an effective and safer alternative for treating breast cancer.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.